Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Sangamo BioSciences (SGMO -3.1%) takes a hit after being downgraded to Underweight from Neutral...

  • Monday, July 2, 2012, 11:49 AM ET
    Sangamo BioSciences (SGMO -3.1%) takes a hit after being downgraded to Underweight from Neutral on valuation at Piper Jaffray, saying the drug developer has limited clinical data coming through its pipeline this year.
Track new comments on this story

This news story has 1 comment:

  •  
    Piper must not have gotten the recent Press releases from SGMO collaborators at Scripts and SIAL new patent apps.
    For further info on the PR, go to Investorvillage.com
    SGMO BB
    2 Jul 2012, 01:41 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »